Stephen W. Potter

Biography

Stephen has more than 15 years of experience as a senior executive in the biotechnology industry. Prior to joining AGTC, he was most recently employed by NeoStem, Inc., a developer of cell-based therapeutics, where Stephen served as Executive Vice President and a member of the Board of Directors. He was Senior Vice President of Operations and Corporate Development for Osiris Therapeutics, Inc., where he was part of the senior leadership team that achieved approval of the first-ever stem cell drug therapy, Prochymal®. Stephen was also responsible for the launch and overall management of the Bio-Surgery business unit as well as operational oversight for mulitple functional areas including manufacturing, human resources, IT, legal and business development. Prior to Osiris, Stephen served as Senior Vice President of Corporate and Business Development at Genzyme Corporation and as Vice President of Corporate and Business Development. Over his ten years at Genzyme, Stephen was the senior leader for its global corporate and business development team that provided strategic and transaction support, including support for many of Genyzme's gene and cell therapy opportunities. He has also held positions at DuPont Pharmaceuticals, E.I. Dupont de Nemours and Company, Inc., and Booz Allen & Hamilton. Stephen earned a B.S. from University of Massachusetts and an MBA from Harvard Business School. 

Research Interest

Business